Press release
North America dominates region with the number of players initiating clinical trials in antiplatelet drugs market
Antiplatelet drugs are wrongly referred to as the blood thinning drugs. They don’t thin the blood but instead interfere with the important process by which blood clots. Antiplatelet agent normally decrease the clumping of blood cells thereby decreasing the potentially harmful blood clots. People who are at high risk of heart disease when given antiplatelet agents, their risks of strokes and heart attacks can be avoided.Antiplatelet agents are widely used in patients having heart attacks as most of the heart attacks are caused by clots in the arteries that feed the heart muscle. Moreover, these are also used in patients who undergo surgical procedure such as angioplasty, which is used to unblock an artery through the insertion of a tube called stent.
To remain ‘ahead’ of your competitors, request for a sample here@ https://www.persistencemarketresearch.com/samples/17062
Antiplatelet Drugs Market: Drivers and Restraints
The antiplatelet drug market is expected to propel during the forecast period owing to the increasing organic and inorganic growth taking place within the industry. Moreover, the market for generic is also at a rise thereby giving a boost to the generic antiplatelet drug manufacturers. The amount of money which the companies are spending towards research and development is also expected to contribute towards the revenue of the antiplatelet drugs market in the future. For instance in February 2017, PLx Pharma announced positive antiplatelet data for its Aspertec drug which was published in the Journal of the American College of Cardiology (JACC). Now researchers are concentrating on analyzing the pharmacodynamics and meta-analyses to determine whether one drug has an edge over other.
Antiplatelet Drugs Market: Segmentation
On the basis of drug type, the antiplatelet drugs market can be segmented as:
Aspirin
Clopidogrel
Ticagrelor
Prasugrel
Dipyridamole
Ticlopidine
Abciximab
Tirofiban
Others
On the basis of application, the antiplatelet drugs market can be segmented as:
Myocardial Infraction
Percutaneous Coronary Interventions
Angioplasty
Arterial Thrombosis
Dental surgeries
Others
On the basis of end user the antiplatelet drugs market can be segment as
Hospitals
Clinic
Emergency Service Centers
Ambulatory surgical centers
Others
Request for Table of Content (TOC) @
https://www.persistencemarketresearch.com/toc/17062
Antiplatelet Drugs Market: Overview
Aspirin is a very well-known antiplatelet drug which has been used since a very long time. Along with Aspirin, there are other three drugs which were approved by FDA in the 1990s. Plavix in 1997, Ticlid in 1991 and Aggrenox in 1999. After these set of drugs Effient was approved by the FDA in 2009. Antiplatelet drugs are just one type of medicine used to treat people with stroke and heart attack. The antiplatelet drugs are usually given along with other medication, lifestyle changes and nondrug treatment to keep the heart healthy.
Antiplatelet Drugs Market: Region-wise Outlook
In terms of geography, Antiplatelet Drugs market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. North America is the dominating region with the number of players initiating clinical trials for the antiplatelet drugs. Moreover, there are many academic universities receiving research grants to develop new product alternatives. For instance, Kengreal, an intravenous antiplatelet drug developed by The Medicines Company received FDA approval. As Asia Pacific is an economically developing country it is expected to spearhead during the forecast period.
Antiplatelet Drugs Market: Key Market Participants
Some of the Antiplatelet Drugs market participants are The Medicines Company, AstraZeneca, The Medicines Company, Portola Pharmaceuticals, Inc., Bayer Pharmaceuticals , Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc. , Altimed Pharma Inc., Dominion Pharmacal, Alta Laboratories Ltd, Novacap, Shandong Xinhua Pharmaceutical, Nanjing Pharmaceutical Factory, Sanis Health Inc, Syntex Inc., Hoffmann La Roche, Teva, Sandoz Canada Incorporated, Pharmascience Inc, Nu Pharm Inc and Mylan Pharmaceuticals
Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
U.S.A - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PersistenceMarketResearch.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America dominates region with the number of players initiating clinical trials in antiplatelet drugs market here
News-ID: 2195636 • Views: …
More Releases from Persistence Market Research
Automotive Relay Market to Reach US$ 30.0 Billion by 2033 at 5.2% CAGR | Key Pla …
The automotive relay market plays a foundational role in modern vehicle electrical and electronic systems, enabling safe and efficient control of high-current circuits using low-power signals. Automotive relays are widely used across vehicles to manage functions such as lighting systems, power windows, fuel pumps, heating and cooling systems, starter motors, and advanced driver-assistance features. As vehicles evolve toward higher electrification and electronic integration, the importance of reliable relay systems has…
Decorative Exterior Materials Market Expected to Reach US$ 417.1 Billion by 2033 …
The decorative exterior materials market represents a vital segment of the global construction and building materials industry, encompassing products designed to enhance the visual appeal, durability, and functional performance of building exteriors. These materials include exterior paints and coatings, cladding systems, facade panels, decorative concrete, stone veneers, exterior tiles, architectural glass, and advanced composite materials. As buildings increasingly serve as expressions of architectural identity and brand value, decorative exterior materials…
Protein Purification Reagents Market Valued at US$ 11.6 Bn in 2026, Set for Stro …
The global protein purification reagents market has experienced robust growth and is expected to continue its upward trajectory in the coming years. The market, valued at USD 11.6 billion in 2026, is projected to reach USD 23.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 10.5% during the forecast period. This growth is primarily driven by the expanding biopharmaceutical research sector, an increasing focus on protein-based…
Automotive Drum Brake Market to Reach US$ 7.9 Bn by 2033 at 4.3% CAGR | Persiste …
The global automotive drum brake market is witnessing steady growth due to its cost-effective, durable, and low-maintenance characteristics. Automotive drum brakes, traditionally used in passenger cars, commercial vehicles, and heavy-duty applications, continue to remain relevant despite the increasing adoption of disc brakes in premium segments. Their robust design and ability to withstand harsh operational conditions make them a preferred choice in emerging economies where affordability and reliability are primary factors…
More Releases for Antiplatelet
Antiplatelet Market Analysis 2024: Size, Share & Growth Report 2032
Allied Market Research added new research on Antiplatelet Market- Global Opportunity Analysis and Industry Forecast, 2022-2032. The Antiplatelet market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon,…
Antiplatelet Market To Witness Strong Growth by 2032 | Astrazeneca, Novartis, Pf …
Allied Market Research added new research on Antiplatelet Market- Global Opportunity Analysis and Industry Forecast, 2022-2032. The Antiplatelet market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon,…
Empowering Lives: Antiplatelet Drugs Market Trends
In 2023, the global antiplatelet drugs market reached an impressive value of USD 2.2 billion. This remarkable growth has been spurred by significant advancements in the pharmaceutical industry and a concerning increase in cases of thrombosis, which encompasses both arterial and venous conditions. As we look ahead to the forecast period of 2024-2032, the market is expected to continue its robust expansion, with a projected compound annual growth rate (CAGR)…
Antiplatelet Market: Advancements in Preventing Blood Clotting Disorders
Allied Market Research Analyst have added a new research study on Title Antiplatelet Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon Inc., Eli Lilly, Bayer AG, Daiichi Sankyo Co. Ltd., Merck, Johnson & Johnson, Novartis, and Pfizer Inc., F.Hoffmann-La Roche AG, Astrazeneca. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies…
The Antiplatelet Drugs Market To Thrive Backed By Wearable Technology
Antiplatelet drugs are incorrectly referred to as blood thinners. They do not thin the blood, but interfere with the vital process by which the blood clots. Antiplatelet drugs usually reduce the aggregation of blood cells, reducing potentially harmful clots. Giving antiplatelet drugs to people at high risk of heart disease can help avoid the risk of stroke and heart attack .
Get Sample Copy of This Report @ …
Antiplatelet Drugs Market - Increasing incidence of cardiovascular diseases is e …
The report presents an in-depth assessment of the Antiplatelet Drugs Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of…
